398 related articles for article (PubMed ID: 21518946)
1. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.
Hajek P; McRobbie HJ; Myers KE; Stapleton J; Dhanji AR
Arch Intern Med; 2011 Apr; 171(8):770-7. PubMed ID: 21518946
[TBL] [Abstract][Full Text] [Related]
2. Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment.
Hajek P; Tønnesen P; Arteaga C; Russ C; Tonstad S
Addiction; 2009 Sep; 104(9):1597-602. PubMed ID: 19686530
[TBL] [Abstract][Full Text] [Related]
3. Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study.
Bolliger CT; Issa JS; Posadas-Valay R; Safwat T; Abreu P; Correia EA; Park PW; Chopra P
Clin Ther; 2011 Apr; 33(4):465-77. PubMed ID: 21635992
[TBL] [Abstract][Full Text] [Related]
4. Increasing varenicline dose in smokers who do not respond to the standard dosage: a randomized clinical trial.
Hajek P; McRobbie H; Myers Smith K; Phillips A; Cornwall D; Dhanji AR
JAMA Intern Med; 2015 Feb; 175(2):266-71. PubMed ID: 25545858
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
Williams JM; Anthenelli RM; Morris CD; Treadow J; Thompson JR; Yunis C; George TP
J Clin Psychiatry; 2012 May; 73(5):654-60. PubMed ID: 22697191
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a flexible quit date versus an a priori quit date approach to smoking cessation: a cross-study analysis.
Hughes JR; Russ CI; Arteaga CE; Rennard SI
Addict Behav; 2011 Dec; 36(12):1288-91. PubMed ID: 21872998
[TBL] [Abstract][Full Text] [Related]
8. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
[TBL] [Abstract][Full Text] [Related]
9. Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomised controlled trial.
Hajek P; Smith KM; Dhanji AR; McRobbie H
BMC Med; 2013 May; 11():140. PubMed ID: 23718718
[TBL] [Abstract][Full Text] [Related]
10. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
Lam S; Patel PN
Cardiol Rev; 2007; 15(3):154-61. PubMed ID: 17438382
[TBL] [Abstract][Full Text] [Related]
11. Varenicline for smoking cessation: a placebo-controlled, randomized study.
Wang C; Xiao D; Chan KP; Pothirat C; Garza D; Davies S
Respirology; 2009 Apr; 14(3):384-92. PubMed ID: 19192221
[TBL] [Abstract][Full Text] [Related]
12. Effect of Extending the Duration of Prequit Treatment With Varenicline on Smoking Abstinence: A Randomized Clinical Trial.
Hawk LW; Tiffany ST; Colder CR; Ashare RL; Wray JM; Tyndale RF; Brandon TH; Mahoney MC
JAMA Netw Open; 2022 Nov; 5(11):e2241731. PubMed ID: 36367720
[TBL] [Abstract][Full Text] [Related]
13. Smoking cessation interventions: a primer for physicians: Comment on "Use of varenicline for 4 weeks before quitting smoking".
Simon JA
Arch Intern Med; 2011 Apr; 171(8):777-8. PubMed ID: 21518947
[No Abstract] [Full Text] [Related]
14. Tobacco dependence treatment for hospitalized smokers: a randomized, controlled, pilot trial using varenicline.
Steinberg MB; Randall J; Greenhaus S; Schmelzer AC; Richardson DL; Carson JL
Addict Behav; 2011 Dec; 36(12):1127-32. PubMed ID: 21835552
[TBL] [Abstract][Full Text] [Related]
15. Varenicline in smoking cessation.
Tonstad S; Rollema H
Expert Rev Respir Med; 2010 Jun; 4(3):291-9. PubMed ID: 20524911
[TBL] [Abstract][Full Text] [Related]
16. Varenicline: a first-line treatment option for smoking cessation.
Garrison GD; Dugan SE
Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839
[TBL] [Abstract][Full Text] [Related]
17. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
Stapleton JA; Watson L; Spirling LI; Smith R; Milbrandt A; Ratcliffe M; Sutherland G
Addiction; 2008 Jan; 103(1):146-54. PubMed ID: 18028247
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
[TBL] [Abstract][Full Text] [Related]
19. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
Tonstad S; Tønnesen P; Hajek P; Williams KE; Billing CB; Reeves KR;
JAMA; 2006 Jul; 296(1):64-71. PubMed ID: 16820548
[TBL] [Abstract][Full Text] [Related]
20. The effects of extended pre-quit varenicline treatment on smoking behavior and short-term abstinence: a randomized clinical trial.
Hawk LW; Ashare RL; Lohnes SF; Schlienz NJ; Rhodes JD; Tiffany ST; Gass JC; Cummings KM; Mahoney MC
Clin Pharmacol Ther; 2012 Feb; 91(2):172-80. PubMed ID: 22130118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
